Skip to Main Content

Paper Details

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
J Immunother Cancer
2
2023
BCL-2-family protein, BCL-XL, CD127, CD25, CD40, CTLA-4, GZMA, GZMB, HLA-DR, Immune dysfunction, RCC, RCC brain metastases, STING, TIM-3, brain, brain metastases, cancer, extracranial, macrophages, patients, primary tumors, renal cell carcinoma, tumor
Author NameAffiliation
Dijana DjureinovicYale School of Medicine
Adebowale J AdeniranYale School of Medicine
Toni K ChoueiriDana-Farber Cancer Institute
Michael E HurwitzYale School of Medicine
David L RimmYale School of Medicine
  • 1 - 5

Datasets

Release 1.2